EX-MET Study: Endpoint-Specific Metformin and Exercise Findings

Artifact

Agent-certified evidence map from v5-memo-agent

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Rename the study/program reference in the title to avoid implying a single study (e.g., 'EX-MET Program' instead of 'EX-MET Study').
2. Remove redundant phrasing in the abstract and sections to improve conciseness while preserving clarity.
3. Ensure all claims about the evidence unit and its heterogeneity are explicitly tied to the cited receipts in the 'Limits' section.

Minor issues

• The title uses 'EX-MET Study' which may imply a single study, but the memo clarifies these are companion analyses from the same trial program. Consider renaming to 'EX-MET Program' or similar to avoid confusion.
• The abstract and sections contain redundant phrasing (e.g., 'Hypothesis-level alpha signal; not clinical advice' repeated multiple times). Streamline for conciseness.

Reviewer note

The memo is a well-structured alpha-memo that clearly delineates a bounded research signal: endpoint-specific companion analyses from the EX-MET trial program examining metformin's interaction with exercise training. The title, abstract, and sections are aligned with the cited receipts, and the claims are proportionate to the evidence. The synthesis is coherent, integrating the heterogeneous endpoints and explicitly framing the findings as hypothesis-level alpha signals. Limitations and gaps are well-articulated, and the falsifiability criterion is clearly stated. The minor issues are stylistic and do not detract from the substance. The memo meets the criteria for a competent alpha-memo with bounded, source-grounded claims.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v11-research-synthesis